|
 |
RaloxifeneThis page contains recent news articles, when available, and an overview of Raloxifene but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Raloxifene (when available) Raloxifene, a selective estrogen receptor modulator (SERM) of the benzothiophene class, is similar to tamoxifen in that it produces estrogen-like effects on bone and lipid metabolism, while antagonizing the effects of estrogen on mammary tissue. Raloxifene decreases bone resorption, increases bone mineral density (BMD) and decreases incidence of fractures. Raloxifene is used in the prevention of postmenopausal osteoporosis and breast cancer. For the prevention of osteoporosis in post-menopausal women Mechanism Of Action: Raloxifene binds to estrogen receptors, resulting in differential expression of multiple estrogen-regulated genes in different tissues. Raloxifene produces estrogen-like effects on bone, reducing resorption of bone and increasing bone mineral density in postmenopausal women. Raloxifene also antagonizes the effects of estrogen on mammary tissue and blocks uterotrophic responses to estrogen. News Articles on Raloxifene Treating breast cancer painful, scary - Jan 4, 2010 I called Dr. Han at Moffitt, and she suggested I try a drug called raloxifene — brand name Evista. Raloxifene, an osteoporosis drug, reduces the occurrence ... The News-Press Options for Bone Loss, but No Magic Pill - Jan 4, 2010 Another effective antiresorptive drug is Evista (raloxifene), which has an added advantage of reducing the risk of breast cancer, but the disadvantage of ... New York Times When Lowering the Odds of Cancer Isn't Enough - Dec 14, 2009 Now another drug, raloxifene, has been shown to have a similar effect, and a class of drugs called aromatase inhibitors may also be useful. ... New York Times Scientists find turmeric and black pepper spices may prevent breast cancer - Dec 29, 2009 ..."Women at high risk of breast cancer right now can choose to take the drugs tamoxifen or raloxifene for prevention, but most women won't take these drugs ... Natural News.com Bone Drugs Taken by Some Women May Lower Breast Cancer Risk, Studies Say - Dec 10, 2009 ...“With tamoxifen and raloxifene, we have drugs that reduce estrogen receptor-positive tumors, but we've never had anything worth anything that prevented ... New York Times Ladies, Pick Your Cancer - Dec 17, 2009 SERMs, like tamoxifen and Evista (raloxifene), could help mammogram readability and even prevent or treat breast cancer, except they increased the risk of ... The Epoch Times Osteoporosis and Erosive Bone Loss: A Complicated Relationship - Dec 17, 2009 ...for osteoporosis (raloxifene, bisphosphonates, hormone replacement, or calcitonin), but they may have been on calcium and vitamin D supplementation. ... Medscape Take a look at year's medical milestones - Dec 20, 2009 ...“Until now, we only can do prophylactic mastectomy (removal of healthy breasts to prevent cancer) or use tamoxifen or raloxifene,â€? which have side effects ... News Sentinel NICE guidelines limit options for low cost osteoporosis drugs - Dec 13, 2009 There are alternatives for those who cannot take alendronate (etidronate, risedronate, or strontium ranelate or, for secondary prevention only, raloxifene) ... News-Medical.net NICE Guidelines Ration Affordable Osteoporosis Drugs - Dec 12, 2009 There are alternatives for those who cannot take alendronate (etidronate, risedronate, or strontium ranelate or, for secondary prevention only, raloxifene) ... Medical News Today (press release) 여성건강ì—? í?¬ì†Œì‹? - Dec 12, 2009 ...ë˜?í•œ 발병 가능성ì?„ ê°€ì§€ê³ ìžˆëŠ” ê±´ê°•í•œ 여성들ì?˜ ìœ ë°©ì•” 예방ì?„ 위해 현재 승ì?¸ë?œ ìœ ì?¼í•œ 약물ì?¸ 호르몬 ì°¨ë‹¨ì œ 타목시펜(Tamoxifen)ê³¼ ëž„ë¡?시펜(Raloxifene)ì?€ í•« ... 미주 한국일보 Medicametele pentru osteoporoza previn cancerul la san - Dec 12, 2009 ...pentru prevenirea cancerului la san in cazul femeilor sanatoase, dar cu grad mare de risc, sunt inhibatoarele de hormoni tamoxifen si raloxifene. ... Ziare.com Chữa bệnh theo đặc tÃnh gen - Dec 12, 2009 Chẳng hạn nhÆ°, trong Ä‘iá»?u trị bệnh loãng xÆ°Æ¡ng, ngÆ°á»?i ta đã phát hiện ra rằng thuốc raloxifene và liệu pháp hormone thay thế có hiệu quả cao vá»›i những ngÆ°á»?i ... Báo Khoa học Suplemen Tulang Cegah Kanker Payudara - Dec 14, 2009 Sampai saat ini obat yang direkomendasikan untuk mencegah kanker payudara pada wanita sehat adalah penghambat hormon yang disebut tamoxifen dan raloxifene. ... Tribun Kaltim Online Le spezie: farmaci naturali contro il cancro al seno - Dec 9, 2009 Al momento, le terapie di prevenzione del tumore al seno prevedono l'utilizzo di tamoxifene o il raloxifene. Tali farmaci presentano alcune ... NEWSFOOD.com Breast Cancer Drugs May Fight Cervical Cancer, Too - Nov 9, 2009 The breast cancer drug fulvestrant and the breast cancer/osteoporosis drug raloxifene were given to mice genetically engineered to carry human ... Atlanta Journal Constitution Drugs to deter cancer largely ignored, experts say - Nov 12, 2009 In 1999, he had a chance to do another breast cancer prevention trial, this time of the drug raloxifene, or Evista. The $110 million study, involving 19000 ... Austin American-Statesman Early tests on cervical cancer drugs - Nov 12, 2009 This research gave an osteoporosis drug called raloxifene, a cancer drug called fulvestrant or no treatment to mice that were genetically engineered to ... Beeston Today Medicines to Deter Some Cancers Are Not Taken - Nov 13, 2009 Then, in 1999, he had a chance to do another breast cancer prevention trial, this time of an osteoporosis drug, raloxifene, or Evista, which did not have ... StarNewsOnline.com How People Learned About Cholesterol - Nov 12, 2009 There are two drugs that can reduce breast cancer risk, tamoxifen and raloxifene, and are approved by the Food and Drug Administration for the purpose. ... New York Times Breast cancer month nearing end - Oct 25, 2009 Further, studies have also revealed that drugs like tamoxifen and raloxifene may reduce breast cancer risk in women. In order to prevent the disease from ... The Money Times Susan G. Komen for the Cure Announces Recipients of 2009 Komen Brinker Award ... - Oct 27, 2009 ...that led to a better understanding of how drugs like tamoxifen and raloxifene work on a molecular level to fight and prevent certain breast cancers. ... Reuters Quandary With Mammograms: Get a Screening, or Just Skip It? - Nov 2, 2009 Also, she said, women should try to get a sense of their own risk, and if it is high, talk to a doctor about taking tamoxifen or raloxifene, drugs that can ... New York Times Jordan Rethinks Hormone's Role in Breast Cancer - Oct 20, 2009 In 1999, Jordan turned his focus to raloxifene. He showed that the drug reduced the risk of breast cancer by 76 percent in postmenopausal women treated for ... Georgetown University News, Calendars & Events I'm 27 and about to have a double mastectomy - Oct 19, 2009 The treatment involves tamoxifen or raloxifene, estrogen blockers that cause temporary, reversible menopause, complete with reduced sexual drive and hot ... msnbc.com Lilly earnings boosted again by Cymbalta and Alimta - Oct 22, 2009 The osteoporosis drug Evista (raloxifene), which is also approved for the prevention of breast cancer for certain postmenopausal women, had revenues of ... Pharma Times Hormone mix may cut breast cancer risk in menopausal women - Oct 19, 2009 Issued by HHS' Agency for Healthcare Research and Quality, the report reveals that the three drugs are tamoxifen, raloxifene, and tibolone. ... Gaea Times (blog) Reducing the risk - Oct 28, 2009 Schocker said, and then there are Tamoxifen and Raloxifene, which are two drugs that have been shown to reduce the risk of breast cancer in clinical ... Altoona Mirror REG-Lilly (Eli) & Co: Lilly Rpts Solid 3Q09; Rev Full-Year 09 EPS Guidance - Oct 21, 2009 Lilly) Evista® (raloxifene hydrochloride, Lilly) Forteo® (teriparatide of recombinant DNA origin injection, Lilly) Gemzar® (gemcitabine hydrochloride, ... Reuters Breast enlargement common in older men - Oct 27, 2009 Raloxifene blocks the effects of estrogen and is another treatment. Surgical removal of the tissue is a definite cure, and the surgery doesn't have a long ... Herald & Review Cancerul de col uterin, vindecat cu medicamente pentru osteoporoza - Nov 10, 2009 ...a doua medicamente numite Fulvestrant si Raloxifene, utilizate in tratarea cancerului de san, respectiv a osteoporozei, scrie, marti, dailymail.co.uk. ... Ziua ìœ ë°©ì•”ì¹˜ë£Œì œ ìž?ê¶?경부암ì—?ë?„ 효과 - Nov 9, 2009 ...주민우 기ìž? [헬스코리아뉴스] ìœ ë°©ì•”ì¹˜ë£Œì œ '플배스트랜(fulvestrant)'ê³¼ 경구용 골다공ì¦? ì¹˜ë£Œì œ 'ëž„ë¡?시펜(raloxifene)' ì?´ ìž?ê¶?경부암ì—?ë?„ 효과가 있다는 연구결과 ... 헬스코리아뉴스 æŸ?些é ?防性藥物å?¯æ¸›å°‘ä¹³ç™Œé¢¨éšªä½†æœƒå¢žåŠ å…¶ä»–é¢¨éšª - Oct 23, 2009 ...波特è˜å¥§å‹’岡å?¥åº·èˆ‡ç§‘å¸å¤§å¸çš„Heidi D. Nelson醫師ç‰äººå¯«é?“，最近的臨床試驗顯示，é?¸æ“‡æ€§é›Œæ¿€ç´ å?—體調節劑tamoxifen citrate與raloxifene以å?Šé?¸æ“‡æ€§çµ„ç¹”é›Œæ¿€ç´ æ´»æ€§èª¿ç¯€ ... 臺灣新浪網 LÆ°á»?i váºn Ä‘á»™ng và cho con bú là m tăng nguy cÆ¡ ung thÆ° vú - Nov 3, 2009 Thuốc Tamoxifen và Raloxifene cÅ©ng là m tăng từ 60 - 90% nguy cÆ¡ tắc nghẽn mạch máu, trong đó Tamoxifen là m tăng nguy cÆ¡ cao hÆ¡n so vá»›i Raloxifene. ... Thanh Tra ê±´ê°•í•œ 중년, 아름다운 여성 - Nov 9, 2009 ...다른 ì¹˜ë£Œì œë¡œëŠ” ì„ íƒ?ì ? ì—?스트로ê²? 수용체 ì¡°ì ˆì œì?¸ ëž„ë¡?시펜(raloxifene)ì?´ 있는ë?° ì?´ëŠ” 열성 í™?ì¡°ì—?는 효과가 없다. ì?´ 외 ì¹¼ì‹œí† ë‹Œ(calcitonin)ì?´ë‚˜ 골형성ì?„ 촉진 ... 쿠키뉴스 æ—¥ ì œë„¤ë¦ ì‹œìž¥ '외ìž?사 진출러시' - Nov 2, 2009 ...rabeprazole), 'ì—?비스타'(Evista, raloxifene), '미카르디스'(Micardis, telmisartan), 'ë ˆí?´ë?¼ìŠ¤íŠ¸'(Reclast, zoledronic acid)ì?˜ 만료가 ì˜ˆì •ë?¼ 있다. ... 디지틀보사 Screening oncologici: pratica utile, inutile o dannosa? - Oct 28, 2009 ...con l'uso di farmaci di provata efficacia preventiva, come la finasteride per il cancro prostatico e tamoxifene e raloxifene per il cancro mammario. ... Pillole.org Un estudio de Novartis determina que Aclasta®, en combinación con teriparatida ... - Oct 20, 2009 Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate. 11 Cosman F, et al. Daily and cyclic parathyroid hormone in ... Noticias Médicas (Comunicado de prensa) Raloxifene or tamoxifen: Which is the right drug for you? - Apr 17, 2006 By Rita Rubin, USA TODAY. As many as 9 million postmenopausal US women might be at an increased risk of breast cancer, scientists say. ... USA Today Another option to prevent breast cancer - Sep 15, 2007 If enough women take raloxifene, "we may see a further decline in breast cancers ... STAR results released last year found that raloxifene was just as ... Pittsburgh Post-Gazette - Pittsburgh Post Gazette Raloxifene Cuts Risk of Certain Type of Breast Cancer - Jun 11, 2008 By Amanda Gardner. WEDNESDAY, June 11 (HealthDay News) -- A drug already approved to reduce the risk of breast cancer in high-risk women also seems to cut ... Washington Post Raloxifene Averts Breast Cancer, at a Risk - Jul 12, 2006 By MARILYNN MARCHIONE. AP. -- Women with heart disease or a high risk for it would trade one set of odds for another if they took the drug raloxifene to try ... Washington Post Raloxifene Safe for Women With Decreased Kidney Function - Apr 9, 2008 By Robert Preidt. WEDNESDAY, April 9 (HealthDay News) -- The osteoporosis drug raloxifene is safe and effective for women with mild to moderate chronic ... ABC News Quality of Life Found Equal With 2 Breast Cancer Drugs - Jun 6, 2006 The breast cancer trial, the Study of Tamoxifen and Raloxifene, or STAR, has been a focus ... Raloxifene, sold by Eli Lilly & Company under the name Evista, ... New York Times Study Sparks Controversy Over Breast Cancer Drugs - Jun 5, 2006 The study compared the old standby, tamoxifen, to raloxifene, ... But raloxifene users had 36 percent fewer uterine cancers and 29 percent fewer blood clots ... FOXNews STAR Study: Raloxifene is as effective as Tamoxifen in reducing... - Apr 20, 2006 By NSABP, The Study of Tamoxifen and Raloxifene, or STAR, is a clinical trial designed see how the drug raloxifene compares with the drug tamoxifen in ... RxPG NEWS FDA Advisers Recommend Raloxifene (Evista) for Prevention of Breast … - Jul 25, 2007 By Peggy Peck, Managing Editor, MedPage Today. ROCKVILLE, Md., July 25 -- An FDA advisory panel has recommended that the agency approve raloxifene (Evista) ... MedPage Today Bone drug prevents one type of breast cancer: study - Jun 10, 2008 Evista, known generically as raloxifene, is already approved for reducing the ... The Raloxifene Use for the Heart (RUTH) trial showed that the drug did not ... Reuters Health: A Better Option? - Apr 24, 2006 Now comes word that another estrogen-like drug, called raloxifene, ... In addition, raloxifene is currently approved only for the treatment and prevention ... TIME No evidence new osteoporosis drugs work better - Dec 17, 2007 But estrogen and raloxifene can have serious side effects such as strokes, blood clots in the lungs or bleeding in the uterus. ... Reuters ASCO - Raloxifene May Protect Against Endometrial Cancer - May 17, 2005 By Megan Rauscher. ORLANDO MAY 17, 2005 (Reuters Health) - A population-based case-control study shows that raloxifene may reduce the risk of endometrial ... Cancerpage.com Breast cancer prevention drug raises fatal stroke risk - Jul 17, 2006 A new study confirmed that the osteoporosis drug raloxifene reduces the risk ... The finding, from the Raloxifene Use for the Heart (RUTH) clinical trial, ... CNN Safety Assessment of Raloxifene Over Eight Years in a Clinical Trial ... - Oct 15, 2005 Objective: Osteoporosis is a chronic disorder that warrants long- term therapy. If benefits are to outweigh risks, the long-term safety profiles of these ... RedOrbit Experts Compare Osteoporosis Drugs - Dec 18, 2007 It also noted that some treatments, such as estrogen and raloxifene, can cause serious side effects such as strokes, blood clots in the lungs, ... Washington Post SCOLR Pharma Reports Raloxifene Study Validates Benefits of CDT(R) … - Jul 11, 2005 BELLEVUE, Wash.--(BUSINESS WIRE)--Aug. 29, 2005--SCOLR Pharma, Inc. (AMEX:DDD) announced today that it has successfully completed pilot bioavailability ... businesswire.com Learn about Raloxifene from Consumer Reports Health. - Jan 3, 2008 Taking raloxifene may increase the risk that you will develop a blood clot in your legs or lungs. ... Full Alert. Raloxifene is used to prevent and treat ... consumerreports.org Too Early to Declare Victory In the War Against Breast Cancer - May 2, 2006 Raloxifene! This drug beat out its cousin tamoxifen, an earlier winner in the ... Raloxifene is being hailed as a preemptive strike against breast cancer, ... Washington Post SCOLR starts raloxifene clinial trials - May 26, 2005 Drug delivery specialist SCOLR Pharma has started pilot testing in Canada of a formulation of the osteoporosis drug raloxifene that promises to improve the ... In-PharmaTechnologist.com Second SERM gets approved to lower breast cancer risk: warning added ... - Oct 1, 2007 Raloxifene, first approved for preventing post-menopausal osteoporosis in 1997 ... Raloxifene was approved for treating postmenopausal osteoporosis in 1999. ... Free with registration - Family Practice News - AccessMyLibrary.com Sorting Out Pills to Reduce Breast Cancer Risk - May 9, 2006 Now a major study has found that another drug, raloxifene, also lowers risk, ... The National Cancer Institute calls raloxifene a "vital option" for women. ... New York Times Extended raloxifene continues to protect some. - Feb 15, 2005 SAN ANTONIO -- Raloxifene continued to markedly reduce breast cancer incidence in postmenopausal osteoporotic women over the course of 8 years in an ... Free with registration - Internal Medicine News - AccessMyLibrary.com When medical reality doesn't match the spin - Jul 18, 2006 Both drugs affected breast cancer incidence equally, but raloxifene has fewer side ... Raloxifene, as headlines and news broadcasts across the country ... msnbc.com Raloxifene vs Tamoxifen - Jan 17, 2007 To the Editor: Dr Vogel and colleagues 1 reported the results of the Study of Tamoxifen and Raloxifene (STAR) P-2 trial. I was disappointed that in the ... Journal of American Medical Association - Journal of American Medical Association... … score IDs risk with raloxifene.(Clinical Rounds)(cerebrovascular... - Nov 1, 2008 Framingham score IDs risk with raloxifene.(Clinical Rounds)(cerebrovascular event risk)(Brief article) ... find Family Practice News articles. Pay-Per-View - Family Practice News - HighBeam Research Effect of Raloxifene on Prevention of Dementia and Cognitive Impairmen... - Apr 23, 2005 Objective: This investigation examined whether raloxifene, a selective estrogen receptor modulator, affects the risk for Alzheimer's disease. ... RedOrbit Analysis: Mixed reults on raloxifene study. - Jul 13, 2006 BOSTON, July 12 (UPI) -- Eli Lilly's osteoporosis drug Evista (raloxifene) does not appear to offer heart protection in postmenopausal women with a history ... Free with registration - UPI Health Business - AccessMyLibrary.com Raloxifene and breast cancer: the CORE study.(Abstract & … - Jan 1, 2005 Synopsis: Raloxifene treatment of postmenopausal women with osteoporosis is associated with a lower incidence of estrogen receptor-positive invasive breast ... Free with registration - Clinical Oncology Alert - AccessMyLibrary.com Raloxifene Side Effects from Consumer Reports Health. - Jan 3, 2008 Taking raloxifene may increase the risk that you will develop a blood clot in your legs or lungs. ... Full Alert. Taking raloxifene may increase the risk ... consumerreports.org FDA Okays Evista for Breast Cancer Prevention in High-Risk Women - Sep 17, 2007 That makes raloxifene, a selective estrogen receptor modulator, ... But, Dr. Galson cautioned, raloxifene can cause serious side effects and "the benefits ... MedPage Today No magic pill, after all - Health & Science - International Herald... - May 10, 2006 The researchers declared victory for raloxifene, saying that it could prevent ... Raloxifene is already on the market as Evista, prescribed to prevent bone ... New York Times Raloxifene cuts risk of memory loss.(UPI Science Report) - Apr 7, 2005 SAN FRANCISCO, April 7 (UPI) -- Women taking raloxifene to prevent osteoporosis also have less risk of memory loss as they age, California researchers ... Free with registration - UPI NewsTrack - AccessMyLibrary.com RALOXIFENE (Oral route) - ral-OX-i-feen.(Drug overview) - May 1, 2007 Raloxifene is used to help prevent and treat thinning of the bones (osteoporosis) only in postmenopausal women. It works like an estrogen to stop the bone ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Women with chronic kidney disease benefit from raloxifene - Apr 23, 2008 In postmenopausal women with mild to moderate chronic kidney disease, raloxifene increases bone mineral density and reduces the risk of vertebral fractures. ... Endocrine Today Raloxifene (Systemic). - Jul 28, 2005 Raloxifene ( ral-OX-i-feen) is used to help prevent and treat thinning of the bones (osteoporosis) only in postmenopausal women. ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Contribution of Raloxifene and Calcium and Vitamin D3 Supplementation... - Jul 1, 2008 G. Boivin, P. Lips, SM Ott, KD Harper, S. Sarkar, KV Pinette and PJ Meunier. Institut National de la Santé et de la Recherche Médicale Unité 403 (GB, PJM), ... Journal of Clinical Endocrinology and... Allentonian says raloxifene is helping her fight breast cancer. - Apr 25, 2006 Apr. 25--An Allentown woman who took part in a national study of two breast cancer prevention medicines credits the osteoporosis medicine raloxifene with ... Free with registration - Morning Call - AccessMyLibrary.com Osteoporosis drug, raloxifene, may lower risk for cognitive impairment... - Jun 1, 2005 A randomized, placebo-controlled trial of over 5000 women has found a one-third lower risk of mild cognitive impairment in postmenopausal women who take 120 ... Free with registration - Brown University Psychopharmacology... - AccessMyLibrary.com Comparison of the Metabolic Effects of Raloxifene and Oral Estrogen... - Dec 1, 2007 Pituitary Research Unit, Garvan Institute of Medical Research (JG, GJ, K.-CL, KKYH), and Department of Endocrinology (KKYH), St. Vincent's Hospital, Sydney, ... Journal of Clinical Endocrinology and... UPMC breast-cancer specialist taking national post - Dec 23, 2008 Dr. Vogel served as the national protocol chairman of the National Cancer Institute's STAR Trial, which studied the drugs Tamoxifen and Raloxifene. ... Pittsburgh Post-Gazette - Pittsburgh Post Gazette Surprising flip-flop in breast cancer drug study - Jun 16, 2006 The study compared the old standby, tamoxifen, to raloxifene, ... But raloxifene users had 36 percent fewer uterine cancers and 29 percent fewer blood clots ... msnbc.com HEALTH: PREVENTING BREAST CANCER FEAR OF PILLS' SIDE … - Aug 26, 2007 Experts hope doctors will feel more comfortable prescribing raloxifene when ... Taking tamoxifen or raloxifene for a few years is known to cut the risk by ... Pay-Per-View - Daily Press - ProQuest Archiver Raloxifene, osteoporosis, and cognitive impairment - Apr 18, 2005 San Francisco, CA - Dr Kristine Yaffe (University of California, San Francisco) reports in the April 2005 issue of the American Journal of Psychiatry that ... Medscape Osteoporosis Drug Raloxifene to Be Trialled in Schizophrenia Treatment - Sep 8, 2008 Australian researchers are to trial raloxifene, now used in osteoporosis and cancer, for schizophrenia treatment. The three-year clinical drug trial follows ... MedIndia Two Drugs, Similar Results. - Jun 21, 2006 21--The osteoporosis drug raloxifene offers women at high risk of breast cancer as ... The Study of Tamoxifen and Raloxifene, or STAR trial, tracked health ... Free with registration - Hartford Courant - AccessMyLibrary.com Osteoporosis; Treatment with raloxifene for 2 years increases... - Feb 15, 2005 2005 FEB 15 - (NewsRx.com & NewsRx.net) -- Treatment with raloxifene for 2 years increases vertebral bone mineral density, volumetric quantitative computed ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Breast Cancer Guidelines Add Raloxifene; Urge Caution With Lab... - Apr 2, 2007 April 2, 2007 — New breast cancer recommendations take recent data into account and include raloxifene for postmenopausal women with lobular carcinoma. ... Medscape Raloxifene Reduces Breast Cancer Risk in Postmenopausal Women at … - Sep 13, 2006 Newswise — Raloxifene protects postmenopausal women from developing invasive breast cancer whether they are at high or low risk of developing the disease, ... newswise.com Raloxifene Reduces Breast Cancer Risk - Jun 20, 2006 Raloxifene, an osteoporosis drug, is effective at protecting high risk women from breast cancer. Research has found that raloxifene is as effective as ... Medical News Today - Medical News Today (press release) Raloxifene halves invasive breast cancer risk: the selective estrogen... - May 15, 2006 Raloxifene is as effective as tamoxifen in preventing invasive breast cancer in postmenopausal women, according to initial results of the Study of Tamoxifen ... Free with registration - Family Practice News - AccessMyLibrary.com Benefits and Risks of Tamoxifen, Raloxifene for Reducing Risk of... - Jun 1, 2006 Newswise — Raloxifene and tamoxifen are both effective in reducing the risk of invasive breast cancer, but each has potential disease and quality of life ... newswise.com Raloxifene Reduces Breast Cancer Risk In Postmenopausal Women At … - Sep 16, 2006 Raloxifene protects postmenopausal women from developing invasive breast cancer whether they are at high or low risk of developing the disease, according to ... Medical News Today - Medical News Today (press release) Stroke risk identified for breast cancer drug - May 25, 2006 Raloxifene, sold as Evista, is a close relative of the older breast cancer ... In April, US researchers reported raloxifene works as well as tamoxifen at ... CBC.ca Raloxifene and Tamoxifen Reduce Breast Cancer Risk - Oct 1, 2006 Clinical Question: What are the relative effects of raloxifene (Evista) and tamoxifen (Nolvadex) on reducing the risk of developing invasive breast cancer? ... AAFP News Now Raloxifene benefits in breast cancer, increases risk of fatal... - Sep 1, 2006 The selective estrogen-receptor modulator (SERM) raloxifene reduces the risks of invasive breast cancer and vertebral fracture in postmenopausal women but ... Free with registration - Formulary - AccessMyLibrary.com Bisphosphonates, calcitonin, raloxifene similarly effective in... - Aug 10, 2008 Results of a large observational study showed no difference in the effectiveness of bisphosphonates in preventing nonvertebral fractures. ... Endocrine Today … drugs were found equally effective but raloxifene produced fewer... - Apr 30, 2006 By Helen Altonn. Two drugs studied in a national clinical trial including Hawaii participants were equally effective in reducing risk of invasive breast ... Honolulu Star-Bulletin Osteoporosis; Treatment with raloxifene for 2 years increases... - Feb 18, 2005 2005 FEB 18 - (NewsRx.com & NewsRx.net) -- Treatment with raloxifene for 2 years increases vertebral bone mineral density, volumetric quantitative computed ... Pay-Per-View - Drug Week - Factiva, from Dow Jones … Trial Site and Personnel in: Effects of Tamoxifen vs Raloxifene on... - Sep 5, 2007 In the "Invasive Breast Cancer" panel of Figure 2 on page 2732, the number at risk in the raloxifene group at 36 months should have been reported as 6702. ... Journal of American Medical Association - Journal of American Medical Association... Raloxifene May Lower Stroke Risk in Some Postmenopausal Women - Feb 21, 2006 Feb. 21, 2006 (Orlando) — Older women with high baseline estradiol levels may have a reduced risk of stroke if they take raloxifene ( Evista), according to ... Medscape Viewpoint: Tamoxifen and Raloxifene Affect Quality of Life Differently - Jul 27, 2006 Patient-Reported Symptoms and Quality of Life During Treatment With Tamoxifen or Raloxifene for Breast Cancer Prevention. The NSABP Study of Tamoxifen and ... Medscape Is Evista A Wonder Drug for Women? - - Aug 29, 2006 The drug in question is raloxifene, sold under the brand name Evista. ... It didn't take long for them to set their sites on raloxifene, which is also a ... $2.95 - Newsweek - NewsBank No magic pill, after all Drugs to reduce breast cancer risk get mixed... - May 11, 2006 The researchers declared victory for raloxifene, saying that it could prevent ... Raloxifene is already on the market as Evista, prescribed to prevent bone ... Pay-Per-View - International Herald Tribune - HighBeam Research Tamoxifen May Not Lengthen Life for Most Breast Cancer Patients - Jul 24, 2006 ...“The fact that the cancers prevented by tamoxifen and (the SERM) raloxifene are easier to treat and have a better prognosis really hasn't been considered ... FOXNews University of Sheffield; UK study finds raloxifene cost effective for... - Mar 16, 2005 2005 MAR 16 - (NewsRx.com) -- An analysis of data from the Multiple Outcomes of Raloxifene (MORE) study in the UK shows raloxifene treatment in ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones Raloxifene fares as well as tamoxifen in 2 related comparison... - Sep 1, 2006 Raloxifene, a second-generation selective estrogen receptor modulator (SERM) approved to treat osteoporosis, fared as effectively against breast cancer as ... Free with registration - Formulary - AccessMyLibrary.com Nation .Breast Cancer Drug .Raloxifene Raises Risk Of Other Ailments . - Jul 13, 2006 A big federal study reported last month that raloxifene was equally ... Roughly half were given daily raloxifene pills and the others, dummy pills. ... Herald-Journal - Google News Archive The SERM of My Dreams -- Johnson 91 (10): 3754 -- Journal of Clinical... - Aug 9, 2006 Raloxifene is a selective estrogen receptor (ER) modulator (SERM) that received United States Food and Drug Administration (FDA) approval in 1997 for the ... Journal of Clinical Endocrinology and... … Does Not Affect Bone Mineral Density Response to Raloxifene - Dec 1, 2007 The effects of raloxifene on hip and spine BMD did not vary by vitamin D status at randomization (P = 0.08 and P = 0.7, respectively). ... Journal of Clinical Endocrinology and... … Benefits and Risks of Tamoxifen and Raloxifene for Reducing the... - Jul 4, 2006 Raloxifene is a second-generation SERM currently used as a medication for ... "In contrast, raloxifene is well known to the primary care community and is ... DG News Bone-loss drug fights prostate cancer - Mar 21, 2006 The researchers tested Raloxifene over two to three years, first via a phase 2 study where they identified a beta isoform of the estrogen receptor in ... United Press International RUTH: Preliminary raloxifene results show no effect on CVD but... - Apr 13, 2006 Indianapolis, IN - Long-term therapy with raloxifene (Evista, Eli Lilly) didn't influence the risk of CVD but apparently protected against development of ... Medscape Osteoporosis drug shown to decrease chances of breast cancer |... - Apr 19, 2006 The drug is raloxifene, sold as Evista. It is the second drug found to reduce the ... Other experts said it was not clear whether raloxifene had significant ... Pay-Per-View - International Herald Tribune - HighBeam Research Raloxifene (Systemic).(Drug overview) - May 1, 2006 Raloxifene ( ral-OX-i-feen) is used to help prevent and treat thinning of the bones (osteoporosis) only in postmenopausal women. ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Osteoporosis Medications - Osteoporosis Health Information - NY Times... - Aug 4, 2008 Raloxifene (Evista) belongs to a class of drugs called selective ... Raloxifene provides the bone benefits of estrogen without increasing the risks for ... New York Times Two Promising Drugs For Breast Cancer - Raloxifene And Lapatinib - Mar 25, 2006 New anticancer drugs are usually developed specially for the job, but occasionally they are borrowed from another field of medicine, ... Medical News Today - Medical News Today (press release) Raloxifene may cut risk of developing endometrial cancer. | Article... - Sep 15, 2005 Raloxifene may cut risk of developing endometrial cancer. ... find Internal Medicine News articles. ORLANDO, FLA. -- Data from a case-control, ... Pay-Per-View - Internal Medicine News - HighBeam Research … and Endometrial Effects of Raloxifene Hydrochloride, a Selective … - Dec 1, 2006 Previous studies of raloxifene conducted in animal models and ... The purpose of this first study of raloxifene in women with normal menstrual cycles was to ... Journal of Clinical Endocrinology and... Raloxifene May Increase Fatal Stroke Risk in Postmenopausal Women - Dec 15, 2006 December 15, 2006 (Chicago) — Further secondary analysis from the Raloxifene Use for the Heart (RUTH) trial shows that although the overall risk for stroke ... Medscape SCOLR Reports Promising Results from Second CDT(R)-Raloxifene Trial - Oct 25, 2006 SCOLR Pharma, Inc. (AMEX : DDD) announced today promising results from its recently completed CDT(R)-raloxifene bioavailability testing in Canada. ... Genetic Engineering News - Genetic Engineering News (press release) A Boost For Breast Cancer Prevention; Osteoporosis Drug Lowers Risk … - Apr 18, 2006 The study of nearly 20000 postmenopausal women found that raloxifene reduces ... The findings indicate that raloxifene, sold under the brand name Evista, ... Pay-Per-View - Washington Post - HighBeam Research Raloxifene Reduces the Risk of Breast Cancer - Apr 1, 2005 Synopsis: This study, the Continuing Outcomes Relevant to Evista (CORE) trial, is a continuation of the Multiple Outcomes of Raloxifene Evaluation (MORE) ... AAFP News Now Osteoporosis; UK study finds raloxifene cost effective for treating... - Mar 17, 2005 2005 MAR 17 - (NewsRx.com) -- An analysis of data from the Multiple Outcomes of Raloxifene (MORE) study in the UK shows raloxifene treatment in ... Pay-Per-View - Women's Health Weekly - Factiva, from Dow Jones Raloxifene Protects Against Breast Cancer Regardless of Risk Category - Sep 29, 2006 NEW YORK SEP 29, 2006 (Reuters Health) - Treatment with raloxifene (Evista; Eli Lilly), which is indicated for the treatment and prevention of osteoporosis, ... Cancerpage.com Do we have a clinically useful breast cancer risk reduction agent for... - Aug 7, 2006 ...(2006) Effects of tamoxifen vs raloxifene on the risk of developing invasive breast ... According to clinical trials studying raloxifene in osteoporosis ... Nature.com Hormone Replacement Therapy (HRT) Breast Cancer - WebMD - Sep 1, 2006 Raloxifene (Evista) is a widely used SERM that has been shown to increase bone growth and density. Unfortunately it does not relieve symptoms of menopause, ... WebMD Note of Caution Over Raloxifene for Breast Cancer Prevention - Oct 13, 2006 October 13, 2006 — A group at Duke University has sounded a note of caution over the use of raloxifene for chemoprevention in women at high risk for breast ... Medscape Osteoporosis treatment: raloxifene (Evista) and stroke mortality - Jul 18, 2006 Reason for posting: Raloxifene is used for the treatment and prevention of osteoporosis. It is a selective estrogen-receptor modulator with estrogen-agonist ... CMAJ Raloxifene strengthens minds as well as bones - May 15, 2005 By Margaret Yole. If Alice had stayed in Wonderland long enough to collect her pension cheque from the Queen of Hearts, she may have sadly ended up like the ... National Review of Medicine Risk Of Invasive Breast Cancer In Older Women Reduced by Anti- … - Aug 10, 2008 Women who took the drug raloxifene were less likely to develop invasive, ... Previous data from the RUTH (Raloxifene Use for The Heart) Trial, ... TopCancerNews.com … comments on results of tamoxifen and raloxifene cancer study... - May 17, 2006 The STAR data, coupled with data from the Raloxifene Use for the Heart (RUTH) ... Raloxifene is not approved by the FDA for preventing or reducing the risk ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones … coronary and breast cancer results from Raloxifene Use for The... - Apr 12, 2006 Raloxifene HCl is currently marketed in the US as Evista for the prevention and treatment of osteoporosis in postmenopausal women. Evista is not approved by ... Pay-Per-View - Company Reports - Factiva, from Dow Jones Raloxifene prevents breast cancer with fewer side effects, study says... - Apr 16, 2006 Called raloxifene, the newer drug already is sold to treat bone-thinning osteoporosis. But the striking new results, from a government study of nearly 20000 ... Herald-Journal - Google News Archive Study: Raloxifene A Tradeoff Of Risks . - Jul 13, 2006 Women with heart disease or a high risk for it would trade one set of odds for another if they took the drug raloxifene to try to prevent breast cancer, ... Lakeland Ledger - Google News Archive A Comparison of the Effects of Raloxifene and Estrogen on Bone in … - Jan 1, 2006 Karen M. Prestwood, Michele Gunness, Douglas B. Muchmore, Yili Lu, Mayme Wong and Lawrence G. Raisz. Center on Aging and Division of Endocrinology and ... Journal of Clinical Endocrinology and... Extended raloxifene use cuts risk of breast Ca.(Gynecology) - Feb 1, 2005 SAN ANTONIO -- Raloxifene continued to markedly reduce breast cancer incidence in postmenopausal osteoporotic women over the course of 8 years in an ... Pay-Per-View - OB GYN News - Factiva, from Dow Jones Chemoprevention for breast ca may be underused.(Women's Health)( … - Jan 15, 2007 SAN ANTONIO -- The efficacy of raloxifene and tamoxifen for pharmacologic ... For primary prevention, the Study of Tamoxifen and Raloxifene (STAR), ... Free with registration - Internal Medicine News - AccessMyLibrary.com Woman's Natural Estrogen Tied to Stroke - Feb 19, 2006 It involved 7290 women who participated in a recent study of raloxifene, ... The study's main aim was testing raloxifene for treating the bone-thinning ... First Coast News … Does Not Affect Bone Mineral Density Response To Raloxifene - May 10, 2005 The effects of raloxifene on hip and spine BMD did not vary by vitamin D ... We conclude that vitamin D status at initiation of raloxifene therapy does not ... Journal of Clinical Endocrinology and... Brand Names/Synonyms: Raloxifene is also known by the following brand names and/or synonymsCCRIS 7129; CHEMBANK1694; Evista; Keoxifene; RAL; Raloxifene; Raloxifene Hcl; Raloxifene Hydrochloride; Raloxifeno [Spanish]; Raloxifenum [Latin] Drug Category: Raloxifene is categorized under the following by the FDA: Antihypocalcemic Agents; Osteoporosis Prophylactic; Selective Estrogen Receptor Modulators; Estrogen Antagonists; ATC:G03XC01 Dosage Forms: Tablet Absorption: Approximately 60% of an oral dose is absorbed, but presystemic glucuronide conjugation is extensive. Absolute bioavailability of raloxifene is 2.0% Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: [6-hydroxy-2-(4-hydroxyphenyl)-benzothiophen-3-yl]-[4-[2-(1-piperidyl)ethoxy]phenyl]-methanone |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
